Bionova Capital

ExtremoChem is a chemical synthesis company dedicated to the development and commercialization of innovative small synthetic molecules designed for the stabilization of biological materials facing stress conditions. The company provides a comprehensive range of services, including accelerated stability studies, pH stability assessments, thermal stability assessments, and aggregation analysis. These services are aimed at supporting life science research organizations, as well as the pharmaceutical, biotech, agrochemical, and chemical industries. ExtremoChem's work enables the stabilization of medicines and proteins that are otherwise unstable at room temperature, facilitating their storage and use in various applications.

Delox designs and develops bio-decontamination devices and automatic decontamination robots that use a solid hydrogen peroxide formulation to deliver rapid, safe disinfection and maintain sterile conditions in healthcare, laboratory and industrial environments. Originating as a spin-off from the University of Lisbon's Faculty of Sciences, the company focuses on compact, cost-effective solutions such as the Delox Box, supported by DeloxHP cartridges that store and release concentrated hydrogen peroxide vapor. Its products enable sterilization of medical devices in hospitals, room decontamination in medical facilities, pharma and food industries, as well as decontamination of laboratory equipment and environmental test chambers. Founded in 2018 and based in Cascais, Portugal, Delox targets facilities that require non-toxic, efficient bio-decontamination to preserve biosafety and reduce downtime.

Founded in 2017, SolasCure is a biotechnology company based in Wales, UK. It specializes in developing innovative hydrogel treatments for patients with chronic wounds. Its flagship product, Aurase, facilitates wound debridement, removing dead or infected tissue to enhance healing.

Founded in 2015, Adapttech is a biomedical company based in Birmingham, UK. It develops smart wearable technologies aimed at improving the quality of life for individuals with physical limitations, particularly those who have experienced lower limb loss. The company's innovative products include the INSIGHT Scanner for creating 3D socket models, the INSIGHT Wearable for real-time bio-data collection, and the INSIGHT App for accessing results anytime.

Vaxdyn is a biotechnology company focused on the development of vaccines and immunotherapies aimed at preventing infectious diseases, particularly those caused by antibiotic-resistant pathogens. Utilizing innovative technology, Vaxdyn's vaccines incorporate antigens, immunomodulators, nanoparticles, and monoclonal antibodies to effectively combat bacterial infections. This approach helps healthcare professionals mitigate the public health impact of infections that are resistant to traditional treatments. The company actively engages with its customers through various communication channels, including phone, email, and online applications, to address inquiries related to their vaccine offerings.

CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.

CellmAbs, established in 2019 and headquartered in Lisbon, Portugal, specializes in developing therapies for glycoimmunology and oncology. As a spin-off from NOVA University of Lisbon, the company focuses on creating solutions for cancer treatment, immunotherapies, and glycobiology. CellmAbs has swiftly grown into an internationally experienced team, having produced several preclinical candidates targeting solid tumors by leveraging advanced knowledge of cancer-specific glycan targets.

Founded in 2017, SolasCure is a biotechnology company based in Wales, UK. It specializes in developing innovative hydrogel treatments for patients with chronic wounds. Its flagship product, Aurase, facilitates wound debridement, removing dead or infected tissue to enhance healing.

Delox designs and develops bio-decontamination devices and automatic decontamination robots that use a solid hydrogen peroxide formulation to deliver rapid, safe disinfection and maintain sterile conditions in healthcare, laboratory and industrial environments. Originating as a spin-off from the University of Lisbon's Faculty of Sciences, the company focuses on compact, cost-effective solutions such as the Delox Box, supported by DeloxHP cartridges that store and release concentrated hydrogen peroxide vapor. Its products enable sterilization of medical devices in hospitals, room decontamination in medical facilities, pharma and food industries, as well as decontamination of laboratory equipment and environmental test chambers. Founded in 2018 and based in Cascais, Portugal, Delox targets facilities that require non-toxic, efficient bio-decontamination to preserve biosafety and reduce downtime.

Founded in 2015, Adapttech is a biomedical company based in Birmingham, UK. It develops smart wearable technologies aimed at improving the quality of life for individuals with physical limitations, particularly those who have experienced lower limb loss. The company's innovative products include the INSIGHT Scanner for creating 3D socket models, the INSIGHT Wearable for real-time bio-data collection, and the INSIGHT App for accessing results anytime.

Anybrain is a technology company specializing in artificial intelligence and data processing. It develops an anti-fraud platform designed to enhance security and fairness in online gaming and esports. The platform uses machine learning algorithms to analyze user interaction patterns with computers via keyboard and mouse, enabling proactive detection of game fraud and abnormal behaviors.

Performetric is a real-time monitoring system that allows the management of mental fatigue in a non-invasive way that aims to develop leisure and work context-aware environments that may improve the quality of life, wellness, mental health and individual performance. Moreover, it also aims to support a better management of the employees and their work time. This translates into a positive impact in the organization’s productivity and an increased quality of life and better health of the employees.